ArticleFrontiers in medicine2025

Preclinical biodistribution and toxicology assessment of an AAV5-based subretinal modifier gene therapy for retinitis pigmentosa.

Arun Upadhyay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.